European Commission Purchases Additional 150m Doses of COVID-19 Vaccine Moderna

Bluebird bio Temporarily Suspends Phase 1/2 and Phase 3 Studies of LentiGlobin Gene Therapy for Sickle Cell Disease

Canada Buys Additional 4m Doses of Moderna's COVID-19 Vaccine

AstraZeneca completes sale of Crestor rights in Europe

Bayer, Orion Expand Development Programme for Nubeqa in Prostate Cancer

4D pharma Inks Clinical Trial Collaboration and Supply Agreement with Merck KGaA and Pfizer to Evaluate MRx0518 in Combination with BAVENCIO for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

Celltrion's COVID-19 Treatment Candidate Receives Korean MFDS Conditional Marketing Authorisation

Merck KGaA names new president of EMD Serono and global head of Innovative Medicine Franchises

GoldenBiotech's New Covid-19 New Drug Candidate Drug Antroquinonol Trial Receives Positive Response from DMC Review and Licenses for 4 Countries

Moderna to Supply Additional 6m Doses of COVID-19 Vaccine Moderna in Switzerland

Tyme Granted US Patent Claims Covering Use of TYME-19 to Treat COVID-19 Infections

Dr. Reddy's Laboratories Launches Vigabatrin Tablets, USP in the US Market

Metrion Biosciences, Sosei Heptares to Explore Structure-based Drug Discovery Approaches to Ion Channels through Strategic Technology Collaboration

First Patient Dosed in European Union as Part of REVERSE-IT Global Phase 3 Trial of Bentracimab for Reversal of Antiplatelet Effects of Ticagrelor

US FDA Accepts Biologics License Application for BAT1706, a Proposed Biosimilar to Avastin